Status:

UNKNOWN

Palliative Dose Escalated Radiation for Painful Non-Spine Bone Metastases and Painful Non-Bone Metas

Lead Sponsor:

Rutgers, The State University of New Jersey

Conditions:

Neoplasm Metastases

Metastases, Neoplasm

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

The investigators hypothesize that with dose escalation to 40-50 Gy in ten fractions, the complete pain response rate at one month can be increased to 40-50% in painful non-spinal bone metastases. Add...

Detailed Description

The purpose of this study is to prospectively evaluate dose escalation and pain response in patients with painful non-spinal bone metastases and painful non-bone metastases treated with radiation ther...

Eligibility Criteria

Inclusion

  • Have provided signed informed consent for the trial
  • Aged ≥18 years at the time of informed consent
  • Histologic proof of malignancy
  • Radiologic or histologic evidence of bone metastases or non-bone metastases
  • Eastern Cooperative Oncology Group (ECOG) Performance Status of ≥3
  • Pain Score ≥ 3
  • Life expectancy of six months or more
  • Willing and able to comply with all aspects of the protocol
  • A female participant is eligible to participate if she is not pregnant and not breastfeeding
  • Woman of childbearing potential who agrees to follow contraceptive guidance during the treatment period and for at least 120 days after the last dose of study treatment.
  • A male participant must agree to use contraception during the treatment period and for at least 120 days after the last dose of study treatment.

Exclusion

  • Metastasis from a highly radiosensitive tumor (eg, lymphoma, myeloma, germ cell tumor)
  • Spinal metastasis
  • Active compression of spinal cord/cauda equina
  • Previous RT or SBRT to the same site
  • \> 3 sites requiring radiation treatment

Key Trial Info

Start Date :

March 16 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 1 2024

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT05419518

Start Date

March 16 2023

End Date

April 1 2024

Last Update

November 14 2023

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

RWJBarnabas Health - Robert Wood Johnson University Hospital

Hamilton, New Jersey, United States, 08690

2

RWJBarnabas Health - Monmouth Medical Center Southern Campus

Lakewood, New Jersey, United States, 08701

3

RWJBarnabas Health - Saint Barnabas Medical Center

Livingston, New Jersey, United States, 10457

4

Robert Wood Johnson University Hospital

New Brunswick, New Jersey, United States, 08901